What is Third Harmonic Bio Inc. (THRD) stock price today?

Third Harmonic Bio Inc. (THRD) currently trades at $5.38 per share. The stock has a market capitalization of $242.79M and a P/E ratio of —x.

Is THRD stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Third Harmonic Bio Inc. has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is 17.98.

Is Third Harmonic Bio Inc. financially healthy?

Third Harmonic Bio Inc.'s Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of 17.98 places it in the safe zone.

THRD

Third Harmonic Bio Inc.

NASDAQ: THRD · HEALTHCARE · BIOTECHNOLOGY

$5.38

+0.00% today

Updated 2026-04-29

Market cap

$242.79M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.24

Dividend yield

—

52W range

$5 – $6

Volume

—

Market cap

$242.79M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.24

Dividend yield

—

52W range

$5 – $6

Volume

—

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

18.0

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$3.00

-44.24%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Altman Z 17.98 — safe zone

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-13.48M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-29.61M	$-37.71M	$-30.82M	$45.47M	$-15.83M
EPS	—	—	—	—	$-1.24
Free cash flow	$-15.78M	$-34.95M	$-20.59M	$-34.51M	$-13.48M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
THRD	$242.79M	32	4.3	3.0	5.0	8.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Third Harmonic Bio Inc. trades at $5.38. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 17.98, it sits in the safe zone.

Frequently asked questions

What is Third Harmonic Bio Inc.'s stock price?

Third Harmonic Bio Inc. (THRD) trades at $5.38.

Is Third Harmonic Bio Inc. overvalued?

Smart Value Score 32/100 (Grade F, Strong Sell).

What is the price target of Third Harmonic Bio Inc. (THRD)?

The analyst target price is $3.00, representing -44.2% downside from the current price of $5.38.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

17.98 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-19.90%

Beta2.13

50D MA$5.40

200D MA$6.51

Shares out0.05B

Float0.02B

Short ratio—

Avg volume—

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

THRD vs LLY →THRD vs JNJ →THRD vs ABBV →Stock screener →